Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in ADMA — Adma Biologics, Inc.

CIK 923093 STAMFORD, CT

Position in ADMA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$6,379,881
+$4,929,692 QoQ
Shares Held
708,089
+790.6% QoQ
Ownership
0.306%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
12 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in ADMA Over Time

Shares Held

Position Value (USD)

Derivatives in ADMA

reported options exposure · as of Mar 31, 2026
CallValue
$10,398,441
CallShares
1,154,100
PutValue
$107,219
PutShares
11,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

TUDOR INVESTMENT CORP ET AL holds $224,177,198 across 117 Biotechnology names. ADMA ranks #8 (2.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 ADMA
Adma Biologics, Inc.
This page
708,089 $6,379,881

All Filings in ADMA

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $107,219 11,900
2026-03-31 $6,379,881 708,089
2026-03-31 $10,398,441 1,154,100
2025-12-31 $2,860,032 156,800
2025-12-31 $1,450,189 79,506
2025-09-30 $337,180 23,000
2025-09-30 $963,909 65,751
2025-09-30 $296,132 20,200
2025-06-30 $402,441 22,100
2025-06-30 $511,701 28,100
2025-03-31 $200,384 10,100
2025-03-31 $329,344 16,600
2024-12-31 $360,150 21,000
2024-12-31 $979,265 57,100
2024-12-31 $387,830 22,614
2024-09-30 $1,507,246 75,400
2024-09-30 $214,792 10,745
2024-06-30 $135,523 12,122
2023-09-30 $622,268 173,818
2023-06-30 $99,452 26,952
2020-06-30 $58,723 20,042
2020-03-31 $272,289 94,545